Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Why CURA Underperforming
View:
Post by ledzep4u on Oct 27, 2022 2:00pm

Why CURA Underperforming

If you want to understand one of the biggest reasons why CURA is underperforming against most of its peers (click on CSE):

https://shortdata.ca/largest-short-positions
Comment by Bullknit101 on Oct 28, 2022 8:30am
Why does the short data reflect 17 May 2021? I don't get it.
Comment by TheProphetElijah on Oct 28, 2022 9:13am
No one believes Biden on this matter, market is reading it as just another ploy for votes going into mid terms.   Unless something of substance happens before then.
Comment by TheProphetElijah on Oct 28, 2022 11:20am
Cura would be netting $30-50m per Q if it wasn't for the 280e.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities